Real-world experience at a Scottish university teaching hospital regarding the tolerability and persistence with topical Ciclosporin 0.1% (Ikervis) treatment in patients with dry eye disease
Crossref DOI link: https://doi.org/10.1038/s41433-018-0289-7
Published Online: 2018-11-29
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hind, Jennifer
Macdonald, Elisabeth
Lockington, David http://orcid.org/0000-0001-7984-0958
Text and Data Mining valid from 2018-11-29
Article History
Received: 2 October 2018
Accepted: 12 November 2018
First Online: 29 November 2018
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.